149Medical

Curated by Signal

Developer of non-invasive monitors for pediatric use

Overview

149 Medical is involved in developing a non-invasive monitor. It measures real-time brain hemodynamics and metabolism in preterm newborns. It allows provides early actionable alerts and continuous feedback.

Key facts

Founded: 2017
Headquarters: Cambridge, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

1 product or service: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

BridGene Biosciences
Developer of small-molecule drugs for the treatment of cancer
Life Sciences TechnologySunnyvale, United States
A2IDEA
Multi-Omic analysis pipelines and statistical algorithms to help cancer researchers
Life Sciences TechnologyAnn Arbor, United States
GL Diabetes
Glucose meters and accessories
Life Sciences TechnologyDover, United States

About 149Medical

What does 149Medical do?

149 Medical is involved in developing a non-invasive monitor.

Where is 149Medical headquartered?

149Medical is headquartered in Cambridge, United States.

When was 149Medical founded?

149Medical was founded in 2017.

Which sector is 149Medical in?

149Medical operates in Life Sciences Technology.

Who are 149Medical's competitors?

Companies similar to 149Medical include BridGene Biosciences, A2IDEA, and GL Diabetes.